Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -709 | -408 | -3,446 | -1,652 | -101 |
| Depreciation Amortization | N/A | N/A | 122 | 122 | 70 |
| Income taxes - deferred | N/A | N/A | 2 | 2 | N/A |
| Accounts payable and accrued liabilities | 74 | 5 | -103 | 43 | 37 |
| Other Working Capital | -531 | -179 | -103 | 6 | -587 |
| Other Operating Activity | -2,508 | -1,291 | -3,643 | -3,838 | -3,439 |
| Operating Cash Flow | $-3,674 | $-1,873 | $-7,171 | $-5,317 | $-4,020 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,604 | 4,103 | 17,622 | 20,227 | 19,300 |
| PPE Investments | N/A | N/A | N/A | N/A | -9,590 |
| Investing Cash Flow | $5,604 | $4,103 | $17,622 | $20,227 | $9,710 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 260 | 6 | -302 | 186 | 186 |
| Other Financing Activity | 0 | 0 | -33,938 | 0 | 0 |
| Financing Cash Flow | $260 | $6 | $-34,240 | $186 | $186 |
| Beginning Cash Position | 49,355 | 49,355 | 73,144 | 73,144 | 73,144 |
| End Cash Position | 51,545 | 51,591 | 49,355 | 88,240 | 79,020 |
| Net Cash Flow | $2,190 | $2,236 | $-23,789 | $15,096 | $5,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,674 | -1,873 | -7,171 | -5,317 | -4,020 |
| Capital Expenditure | 0 | N/A | N/A | N/A | -9,590 |
| Free Cash Flow | -3,674 | -1,873 | -7,171 | -5,317 | -13,610 |